A detailed history of Berry Street Capital Management LLP transactions in Seagen Inc. stock. As of the latest transaction made, Berry Street Capital Management LLP holds 206,250 shares of SGEN stock, worth $0. This represents 12.86% of its overall portfolio holdings.

Number of Shares
206,250
Previous 87,500 135.71%
Holding current value
$0
Previous $16.8 Million 159.83%
% of portfolio
12.86%
Previous 3.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$191.51 - $216.16 $22.7 Million - $25.7 Million
118,750 Added 135.71%
206,250 $43.8 Million
Q2 2023

Aug 11, 2023

BUY
$187.64 - $206.25 $11.7 Million - $12.9 Million
62,500 Added 250.0%
87,500 $16.8 Million
Q1 2023

May 12, 2023

BUY
$127.59 - $203.08 $3.19 Million - $5.08 Million
25,000 New
25,000 $5.06 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Berry Street Capital Management LLP Portfolio

Follow Berry Street Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berry Street Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Berry Street Capital Management LLP with notifications on news.